Cargando…
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
BACKGROUND: More than half of patients with multiple sclerosis have progressive disease characterised by accumulating disability. The absence of treatments for progressive multiple sclerosis represents a major unmet clinical need. On the basis of evidence that mesenchymal stem cells have a beneficia...
Autores principales: | Connick, Peter, Kolappan, Madhan, Crawley, Charles, Webber, Daniel J, Patani, Rickie, Michell, Andrew W, Du, Ming-Qing, Luan, Shi-Lu, Altmann, Daniel R, Thompson, Alan J, Compston, Alastair, Scott, Michael A, Miller, David H, Chandran, Siddharthan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Pub. Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279697/ https://www.ncbi.nlm.nih.gov/pubmed/22236384 http://dx.doi.org/10.1016/S1474-4422(11)70305-2 |
Ejemplares similares
-
The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments
por: Connick, Peter, et al.
Publicado: (2011) -
Experimental and Therapeutic Opportunities for Stem Cells in Multiple Sclerosis
por: Patani, Rickie, et al.
Publicado: (2012) -
Hypothermic Preconditioning of Human Cortical Neurons Requires Proteostatic Priming
por: Rzechorzek, Nina Marie, et al.
Publicado: (2015) -
Activin/Nodal Inhibition Alone Accelerates Highly Efficient Neural Conversion from Human Embryonic Stem Cells and Imposes a Caudal Positional Identity
por: Patani, Rickie, et al.
Publicado: (2009) -
Human Stem Cell-Derived Neurons: A System to Study Human Tau Function and Dysfunction
por: Iovino, Mariangela, et al.
Publicado: (2010)